| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K71781559 |
| PharmacoGx | BRD-K71781559 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NCAPD2 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | KRT27 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | FBXO43 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | OR1L1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | CCNK | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | DAGLA | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | CDH3 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | ZNF227 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | TCAF2 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | TRPS1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.07 |
